The Lyme disease vaccine study

With your help, we can tackle Lyme disease

Lyme disease is a tick-borne disease that can cause serious long-term symptoms if left untreated. For people living in areas where ticks are common, a preventive vaccine would be better than current measures such as insecticides and tick control. Currently, there are no approved vaccines available to prevent Lyme disease in exposed populations. This clinical trial1 will evaluate whether a study vaccine is safe and effective in preventing Lyme disease in people 5 years of age and older. By choosing to participate as a voluntary study participant, you will represent others like you – of the same age, of the same ethnic background, and from communities like yours.

Joining a clinical trial is an important and personal decision for you and your family. We hope it is a decision you will consider.

Who can participate?

Healthy children (between 5 and 17 years of age) and adults (18 years of age and older) who live in places or participate in activities that increase the risk of Lyme disease may be eligible to participate. Risk factors for Lyme disease include:

  • Outdoor work such as landscape maintenance, forestry, management of wild animals and plants and park management.
  • Regular outdoor leisure activities such as hiking, camping, fishing, hunting or gardening.
  • Living or frequenting wooded areas, tree lines, tall grass, open fields as well as beaches by seas, lakes and other bodies of water.
  • Owning a pet that can carry ticks after being outdoors.

Note! These are not the only eligibility criteria for this clinical research study. A member of the clinical study staff will help determine if this study is right for you based on all the eligibility criteria.

About the Lyme disease vaccine study

This study compares the investigational vaccine (study vaccine) with a placebo (injection without active substance) to find out whether it is safe and effective in preventing Lyme disease. If you choose to participate, you will receive 3 [4] injections in the upper arm and be asked to attend at least 7 in-person study visits over the course of 30 months. You can change your mind and leave the study at any time. There is no cost to participate and you will be reimbursed for expenses and time in connection with the performance of certain study tasks.

Interested?

To learn more about this study, contact:

Ewa Karlsson, phone 0732-300 450 or email ewa.karlsson@probare.se